<VariationArchive RecordType="classified" VariationID="436098" VariationName="NM_000275.3(OCA2):c.171del (p.Gln58fs)" VariationType="Deletion" Accession="VCV000436098" Version="6" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-09" DateCreated="2017-08-28" MostRecentSubmission="2017-08-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="429641" VariationID="436098">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.3(OCA2):c.171del (p.Gln58fs)</Name>
      <CanonicalSPDI>NC_000015.10:28081703:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="28081704" stop="28081704" display_start="28081704" display_stop="28081704" variantLength="1" positionVCF="28081703" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28326850" stop="28326850" display_start="28326850" display_stop="28326850" variantLength="1" positionVCF="28326849" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q58fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.28081706del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.28081706del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28326852del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28326852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.1" sequenceAccession="NG_009846" sequenceVersion="1" change="g.22609del">
            <Expression>NG_009846.1:g.22609del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000275.3" sequenceAccession="NM_000275" sequenceVersion="3" change="c.171del" MANESelect="true">
            <Expression>NM_000275.3:c.171del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000266.2" sequenceAccession="NP_000266" sequenceVersion="2" change="p.Gln58fs">
            <Expression>NP_000266.2:p.Gln58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300984.2" sequenceAccession="NM_001300984" sequenceVersion="2" change="c.171del">
            <Expression>NM_001300984.2:c.171del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287913.1" sequenceAccession="NP_001287913" sequenceVersion="1" change="p.Gln58fs">
            <Expression>NP_001287913.1:p.Gln58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645373000" DB="ClinGen" />
        <XRef Type="rs" ID="1555391997" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.3(OCA2):c.171del (p.Gln58fs) AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV000500321" Version="6">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-08-28" MostRecentSubmission="2017-08-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1152607" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_000275.2(OCA2):c.171del|Albinism, oculocutaneous, type II" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000596153" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.2:c.171del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Albinism, oculocutaneous, type II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1152607" TraitType="Disease" MappingType="Name" MappingValue="Albinism, oculocutaneous, type II" MappingRef="Preferred">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

